Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMG1 | Q96Q15 | 8/20 | 0.61 |
| ▸ | CDK1 | P06493 | 5/20 | 0.61 |
| ▸ | CDK2 | P24941 | 5/20 | 0.61 |
| ▸ | ABL1 | P00519 | 1/20 | 0.53 |
| ▸ | BCR | P11274 | 1/20 | 0.53 |
| ▸ | PRKCA | P17252 | 1/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.53 |
| ▸ | CAMK2D | Q13557 | 6/20 | 0.52 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.51 |
| ▸ | MTOR | P42345 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | CDK4 | P11802 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.49 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.49 |
| ▸ | XBP1 | P17861 | 1/20 | 0.49 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.49 |
| ▸ | CCND1 | P24385 | 1/20 | 0.49 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6094300 | 0.82 | SMG1 (0.61) | SMG1CDK1CDK2ABL1BCR | |
| SCHEMBL6095791 | 0.82 | SMG1 (0.61) | SMG1CDK1CDK2ABL1BCR | |
| SCHEMBL6095641 | 0.82 | SMG1 (0.61) | SMG1CDK1CDK2ABL1BCR | |
| SCHEMBL6095801 | 0.81 | SMG1 (0.68) | SMG1CDK1CDK2ABL1BCR | |
| SCHEMBL6095532 | 0.81 | SMG1 (0.62) | SMG1CDK1CDK2ABL1BCR | |
| SCHEMBL27598229 | 0.80 | SMG1 (0.58) | SMG1CDK1CDK2ABL1BCR | |
| SCHEMBL27598230 | 0.80 | SMG1 (0.58) | SMG1CDK1CDK2ABL1BCR | |
| SCHEMBL27598279 | 0.80 | SMG1 (0.58) | SMG1CDK1CDK2ABL1BCR | |
| SCHEMBL6096290 | 0.79 | SMG1 (0.59) | SMG1CDK1CDK2ABL1BCR | |
| SCHEMBL6093759 | 0.79 | SMG1 (0.61) | SMG1CDK1CDK2ABL1BCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7074787-B2 | Microbiocidal N-phenyl-N-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2006-07-11 | — | — | US | claimed |
| EP-1349849-B1 | MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL)-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-09-15 | — | — | EP | claimed |
| US-20040063937-A1 | Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives | SYNGENTA CROP PROTECTION, INC. | 2004-04-01 | — | — | US | claimed |
| EP-1349849-A1 | MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL)-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES | Syngenta Participations AG (CH) | 2003-10-08 | — | — | EP | claimed |
| WO-2002053560-A1 | MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2002-07-11 | — | — | WO | claimed |
| US-7074787-B2 | Microbiocidal N-phenyl-N-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2006-07-11 | — | — | US | disclosed |
| EP-1349849-B1 | MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL)-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-09-15 | — | — | EP | disclosed |
| US-20040063937-A1 | Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives | SYNGENTA CROP PROTECTION, INC. | 2004-04-01 | — | — | US | disclosed |
| EP-1349849-A1 | MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL)-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES | Syngenta Participations AG (CH) | 2003-10-08 | — | — | EP | disclosed |
| WO-2002053560-A1 | MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2002-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063937-A1 | Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives | CCR8, MSR1, TLR8 | SMG1 1019/4885CDK1 4719/4885CDK2 4694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.